Caplight Directory>Companies>Windward Bio-preview>Windwardbio


Windward Bio

Windward Bio

Private
BaselN/Ahttps://windwardbio.com/

Last Round

Growth Equity

May 4, 2026

Total Funding Raised

$165M

Momentum Score

25 /100

Company Overview

Windward Bio is a biotechnology company that develops long-acting antibody therapies for immunological, respiratory, and dermatological diseases.

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Windward Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Windward Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Growth EquityMay 4, 2026
View all Funding Rounds

Key People

Founding team and executive leadership

Luca Santarelli

Founder, CEO And Chairman

Founding Team

Teit Agger

Chief Technology Officer

Executive Team

Claudia D'Augusta

Group CFO

Executive Team

Windward Bio Investors

Notable investors and investment history

InvestorRounds
Janus Henderson GroupGrowth Equity
RA Capital ManagementGrowth Equity
Omega FundsGrowth Equity
OrbiMedGrowth Equity
Novo HoldingsGrowth Equity
Sanofi VenturesGrowth Equity
Pivotal bioVenture PartnersGrowth Equity
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 4, 2026

    $165M round led by OrbiMed.

  • Feb 20, 2026

    Grew 50% QoQ, from 26 to 39 employees.

View all signals

Windward Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Windward Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Windward Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel
Employee Range40
Year Founded2024
Last FundingMay 4, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.